Ultragenyx: Independent Medical Education Grants

Ultragenyx: Independent Medical Education Grants

Status: ACTIVE
Funder: Ultragenyx
Last Updated: October 07, 2025

Summary

Ultragenyx offers Independent Medical Education Grants aimed at supporting educational initiatives focused on rare diseases. These grants cater to both accredited and non-accredited programs, enhancing healthcare education for providers. Requests for funding should be submitted 30 to 60 days prior to the required decision date, with a thorough review process in place. The areas of interest include X-Linked Hypophosphatemia, Tumor Induced Osteomalacia, and more, contributing to impactful resources for the rare disease community.

Overview

NOTE: We require all funding applications be submitted through our Grants Portal Requests for grant funding should be submitted 30 days prior to the date you require a decision or a minimum of 60 days prior to your program start date, though longer periods are encouraged. All applications are formally and thoughtfully reviewed by a dedicated committee(s) of representatives. Once submitted, you will be notified by email with our decision. Grants and contributions Ultragenyx is committed to supporting initiatives that provide impactful resources for the rare disease community, healthcare education, STEAM education, and local community organizations. Independent Medical Education Grants Ultragenyx offers educational grants for accredited and non-accredited clinical, technical, and scientific programs or continuing medical education activities focused on rare diseases for healthcare providers. In certain clinical areas, a request for proposal (RFP) will be posted to this site for independent medical education. Please check back for more information or reach out to Ultragenyx Grants Program.

Eligibility

You can learn more about this opportunity by visiting the funder's website. We are currently considering independent medical education in the following areas:X-Linked Hypophosphatemia (XLH)Tumor Induced Osteomalacia (TIO)Mucopolysaccharidosis Type VII (MPSVII)Long Chain Fatty-Acid Oxidation Disorders (LC-FAOD)Homozygous Familial Hypercholesterolemia (HoFH) – ex-US onlyGeneral Gene Therapy Education